A Study of SYH2092 Injection in Healthy Participants
NCT07776041 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2026-08-20
Summary
To evaluate the safety and tolerability of SYH2092 Injection in healthy participants
Conditions
- Overweight or Obesity
Interventions
- DRUG
-
SYH2092 Injection
Conduct in accordance with the study protocol.
- DRUG
-
Conduct in accordance with the study protocol.
Sponsors & Collaborators
-
CSPC Megalith Biopharmaceutical Co.,Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-30
- Primary Completion
- 2027-02-09
- Completion
- 2027-04-20
Countries
- Australia
Study Locations
More Related Trials
-
A Study of HS-20094 in Chinese Adults With Overweight or Obesity
NCT06839664 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity
NCT06226090 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
NCT06972992 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-20094 in Overweight or Obese Participants
NCT07057674 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of SA030 Injection in Overweight or Obese Participants
NCT07479862 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05313802 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
NCT04605861 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes
NCT04799327 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
NCT03254368 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TG103 Injection in Overweight or Obesity
NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2
-
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
NCT02970942 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults
NCT07697846 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
NCT07192263 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity
NCT06595238 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity
NCT07690826 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
NCT05751226 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
NCT07187856 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
NCT07036601 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
NCT06606106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants
NCT07230496 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
NCT07608770 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
NCT06683508 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
NCT04238962 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT05950516 ·Status: UNKNOWN ·Phase: PHASE3
-
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480 ·Status: COMPLETED ·Phase: PHASE1